The effects of arginine glutamate, a promising excipient for protein formulation, on cell viability: Comparisons with NaCl  by Kheddo, Priscilla et al.
Toxicology in Vitro 33 (2016) 88–98
Contents lists available at ScienceDirect
Toxicology in Vitro
j ourna l homepage: www.e lsev ie r .com/ locate / tox inv i tThe effects of arginine glutamate, a promising excipient for protein
formulation, on cell viability: Comparisons with NaClPriscilla Kheddo a,b, Alexander P. Golovanov a,b, Kieran T. Mellody b, Shahid Uddin c,
Christopher F. van der Walle c, Rebecca J. Dearman b,⁎
a Manchester Institute of Biotechnology, University of Manchester, Manchester M1 7DN, UK
b Faculty of Life Sciences, University of Manchester, Manchester M13 9PL, UK
c MedImmune Ltd, Granta Park, Cambridge CB21 6GH, UKAbbreviations: 7-AAD, 7-aminoactinomycin D; ANOVA
APC, allophycocyanin; Arg·Glu, arginine glutamate; Arg·H
bovine serum albumin; DC, dendritic cell; EDTA, ethylene
enzyme-linked immunosorbant assay; FCS, fetal calf
Administration; FITC, ﬂuorescein isothiocyanate; FS
Generally Recognized as Safe; HLA-DR, human leukocyt
tion/osmolality required to cause a 50% loss in viability;
molecule 1; IL, interleukin; LPS, lipopolysaccharide; MF
NaGlu, sodium glutamate; PBS, phosphate buffered salin
side scatter; TLR, toll-like receptor; TNF, tumor necrosis fa
⁎ Corresponding author.
E-mail address: rebecca.dearman@manchester.ac.uk (
http://dx.doi.org/10.1016/j.tiv.2016.02.002
0887-2333/© 2016 The Authors. Published by Elsevier Ltda b s t r a c ta r t i c l e i n f oArticle history:
Received 3 November 2015
Received in revised form 28 January 2016
Accepted 6 February 2016
Available online 10 February 2016The effects of an equimolar mixture of L-arginine and L-glutamate (Arg·Glu) on cell viability and cellular stress
using in vitro cell culture systems are examined with reference to NaCl, in the context of monoclonal antibody
formulation. Cells relevant to subcutaneous administration were selected: the human monocyte cell line THP-
1, grown as a single cell suspension, and adherent human primary ﬁbroblasts. For THP-1 cells, the mechanism
of cell death caused by relatively high salt concentrations was investigated and effects on cell activation/stress
assessed as a function of changes in membrane marker and cytokine (interleukin-8) expression. These studies
demonstrated that Arg·Glu does not have any further detrimental effects on THP-1 viability in comparison to
NaCl at equivalent osmolalities, and that both salts at higher concentrations cause cell death by apoptosis;
there was no signiﬁcant effect on measures of THP-1 cellular stress/activation. For adherent ﬁbroblasts, both
salts caused signiﬁcant toxicity at ~400 mOsm/kg, although Arg·Glu caused a more precipitous subsequent de-
cline in viability than did NaCl. These data indicate that Arg·Glu is of equivalent toxicity to NaCl and that the
mechanism of toxicity is such that cell death is unlikely to trigger inﬂammation upon subcutaneous injection
in vivo.
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Since the licencing by theUS Food andDrugAdministration (FDA) in
1986 of the ﬁrstmonoclonal antibody therapy, amurine IgG2a anti-CD3
antibody for the treatment of solid organ transplant rejection, the ﬁeld
has expanded rapidly (Hooks et al., 1991; Singleton, 2014; Walsh,
2010). These targeted biological therapies are now used for the treat-
ment of a range of diseases including rheumatoid arthritis, psoriasis, in-
ﬂammatory bowel disease and cancer (Lynch et al., 2014; Sedger
and McDermott, 2014; Pandey and Mahadevan, 2014). Indeed, in
2012 three monoclonal antibodies that target the proinﬂammatory, one-way analysis of variance;
Cl, arginine hydrochloride; BSA,
diaminetetraacetic acid; ELISA,
serum; FDA, Food and Drug
C-H, forward scatter; GRAS,
e antigen; IC50, the concentra-
ICAM-1, intercellular adhesion
I, mean ﬂuorescence intensity;
e; PI, propidium iodide; SSC-H,
ctor.
R.J. Dearman).
. This is an open access article undercytokine tumor necrosis factor (TNF)-α (adalimumab, inﬂiximab and
entanercept) were the world's top selling medicines in that year (Ho
and Chien, 2012).
The formulation process in the biopharmaceutical industry requires
the quantitative characterization of several potential degradation path-
ways, both covalent (e.g. oxidation, deamidation, proteolysis) and non-
covalent (e.g. aggregation, unfolding-denaturation, phase separation)
(Razinkov et al., 2015). The formulation that is selected must impart a
long term stability to the product, at least over the required shelf-life,
storage temperature and shipping conditions. It is the composition of
the aqueous environment (buffer pH, ionic strength, excipient, etc.)
that plays a critical role in maintaining the colloidal stability of an anti-
body in solution (Roberts et al., 2015). Various excipients (additives)
have been used to optimize protein stability of pharmaceutical products
and to minimize the extent of aggregation (Kamerzell et al., 2011).
These include amino acids, such as histidine, arginine, and glycine
(Arakawa et al., 2007a), sugars, such as trehalose (Kaushik and Bhat,
2003). There are several mechanisms by which small molecule excipi-
ents are proposed to stabilize proteins, including preferential interac-
tion, preferential hydration and excluded volume (Bye et al., 2014). It
is currently not possible to select excipients for a particular mAb formu-
lation a priori, although platform approaches in the industrymay favourthe CC BY license (http://creativecommons.org/licenses/by/4.0/).
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cipients to be included in a buffer in order to stabilize the protein formu-
lation may be carried out by analysis of data generated by high
throughput biophysical assays (Cheng et al., 2012).
Arginine is of particular interest as an excipient used to suppress
protein aggregation, with several groups working on the elucidation of
itsmechanismof action. Theweak interactions of argininewith the pro-
tein surface are due to its afﬁnity for some amino acid side chains and
the peptide backbone, but this is balanced by repulsion from the protein
surface on account of an increase in the surface tension and volume ex-
clusion effects (a complete review is given by Arakawa et al. (2007b)).
The net effect of the preferential inclusion versus exclusion of arginine
from the protein surface is dependent on its concentration, with an ap-
parent saturation of the protein surface at around 0.5 M, above which
arginine is considered to be excluded (Schneider and Trout, 2009). In
silico modelling suggests that arginine cations cluster at certain protein
surface patches via interaction with guanidinium and carboxylate
amino acid side chains (Vagenende et al., 2013). However, the salt
forms of excipients containing charged groups (or ion–ion pairs) are
also known to play an important role in determining the mechanism
of action in regard to protein stabilization. This is especially true for
various salt forms of arginine, whose ability to suppress protein aggre-
gationwas shown to follow the empirical Hofmeister series; phosphate,
sulphate and citrate more strongly interacting with the arginine cation
and suppressing aggregation (Schneider et al., 2011). Given the impor-
tance of the salt form of arginine, one such excipient currently being ex-
plored in the area of biopharmaceutics is an equimolar mixture of
amino acids L-arginine and L-glutamate (Arg·Glu salt). This excipient
has been shown to increase protein solubility and stability and has
been used in the ﬁelds of structural biology and vaccine development
for some time (Blobel et al., 2011; Golovanov et al., 2004; Mistilis
et al., 2015; Vedadi et al., 2006). These amino acids are a natural constit-
uent of organisms and cells, they are part of human diet, and therefore
inherently are non-toxic. Initial experiments have indicated that
Arg·Glu can suppress aggregation ofmonoclonal antibody preparations
induced by increased temperatures or pH and was also effective under
accelerated stability conditions at weakly acidic to neutral pH
(Kheddo et al., 2014).
In practice, excipients used for patient-injected formulations, includ-
ing L-Arg and L-Glu, are chosen from the Generally Recognized as Safe
(GRAS) category (US Food and Drugs Agency [FDA], 1982; Ogaji et al.,
2011; Pifferi and Restani, 2003). However, the higher Arg·Glu concen-
trations (e.g. ≥200 mM in the ﬁnal formulation, Kheddo et al., 2014),
which may be necessary for optimal protein solubility, increase osmo-
lality and hence may affect cell viability in vitro or in vivo or cause cel-
lular stress (Vázquez-Rey and Lang, 2011). Indeed, the tolerability of
hypertonic injectables has been reviewed recently (Wang, 2015). For
drug products intended for subcutaneous injection, the main potential
adverse effects were identiﬁed as enhanced site pain, local irritation
and possible tissue damage and it was recommended that for drug
products intended for subcutaneous injection, the upper osmolality
limit should be 600mOsm/kg (Wang, 2015). Changes to tissue osmolal-
itymay also cause activation of local dendritic cells (DC), sentinel cells of
the immune system, acting as a trigger for inﬂammation (Gallo and
Gallucci, 2013). These cells are activated by so-called “danger signals”
which may derive directly from pathogens or dying host cells and also
may be associated with perturbations of tissue/cell homeostasis such
as changes in osmolality. Hypotonicity has been shown to act as a dan-
ger signal (Compan et al., 2012) and there are also reports that osmotic
shock due to hypertonicity induced the production of the proinﬂamma-
tory cytokine interleukin (IL)-8 by human peripheral bloodmononucle-
ar cells (Shapiro and Dinarello, 1997) and upregulation of macrophage
caspase-1 (Ip and Medzhitov, 2015).
The aim of the current investigations was to examine the effects of
increased concentrations of Arg·Glu on cell viability and cellular stress
using in vitro cell culture systems. Similar studies have been conductedpreviously to investigate the impact of excipients within formulations
on cell viability (Gursoy et al., 2003; Lee et al., 2013; Ménard et al.,
2012; Nogueira et al., 2011). Cells of relevance to the subcutaneous
route of administration have been selected (Kagan, 2014): the human
monocyte cell line THP-1 (a surrogate DC line; Megherbi et al., 2009),
grown as a single cell suspension, and human primary ﬁbroblasts,
cultured as an adherent monolayer. Thus, the impact on cell viability
of increasing osmolalities of L-Arg and L-Glu solutions (together and
separately) has been examined in comparison with the reference stan-
dard NaCl. In addition, for THP-1 cells, the mechanism of cell death
which these different salts cause at relatively high concentrations has
been investigated by ﬂow cytometry, allowing differentiation between
death by necrosis and death by apoptosis (otherwise known as pro-
grammed cell death) (Kabakov et al., 2011). More subtle effects of the
presence of Arg·Glu on cell activation have been assessed as a function
of changes in membrane marker expression on activated THP-1 cells
(Megherbi et al., 2009).
2. Methods
2.1. Cell line maintenance
The THP-1 human monocytic leukaemia cell line (Sigma-Aldrich
Chemical Co.; Poole, Dorset, U.K.) was cultured in RPMI-1640 medium
(Sigma) supplemented with 400 μg/mL streptomycin, 400 μg/mL
penicillin (both from Sigma), 2 mM L-glutamine (GIBCO; Paisley,
Renfrewshire, UK) and 10% fetal calf serum (FCS; GE Healthcare,
Cambridge, UK). THP-1 cells were maintained in vented T75 ﬂasks at
37 °C in an atmosphere of 5% CO2 and split every 3–4 days when conﬂu-
ent (N2 × 106 cells/mL). Primary ﬁbroblasts from human explants
were cultured in DMEM medium (high glucose [4.5 g/L] with 2 mM
L-Glutamine; GIBCO) supplemented with 400 μg/mL streptomycin,
400 μg/mL penicillin, 2 mM GlutaMax (GIBCO), 0.25 μg/mL
amphotericin B (Sigma) and 10% FCS. Fibroblasts were maintained in
10 cm culture dishes at 37 °C/5% CO2 and passaged every 3–4 days
when N80% conﬂuent. Cell number was assessed by exclusion of 0.5%
trypan blue using a hemocytometer.
2.2. Salts used for generating changes in osmolality
Stock solutions of cell culture grade arginine glutamate (Arg·Glu)
from equimolar mixtures of L-Arg (CAS number 74–79-3) and L-Glu
(CAS number 142–47-2), NaCl (CAS number 7647–14-5), L-arginine hy-
drochloride (Arg·HCl; CAS number 1119–34-2) and sodium glutamate
(NaGlu; CAS number 56–86-0) (all from Sigma-Aldrich) were prepared
at 2.24M, 4.96M, 4.32Mand 3.9M, respectively, in RPMI-1640medium
supplemented as described above without FCS. The salts of the amino
acids (rather than the free bases) were used to keep the pH of L-Arg
and L-Glu amino acid solutions within physiological range, whereas to
prepare Arg·Glu, free bases of these amino acids were mixed together.
Solutions were ﬁltered using a 0.22 μm syringe ﬁlter and stored at 4 °C
until use.
2.3. Determination of osmolality of salt solutions
The osmolality of Arg·Glu, NaCl, Arg·HCl and NaGlu solutions was
measured using an Osmomat 030-D Cryoscopic Osmometer (Gonotec
GmbH, Berlin, Germany) following standard operating procedures. A
1 M stock solution formulated in RPMI media was prepared for each
salt and ﬁnal concentrations of 5, 100, 150 and 200 mMwere prepared
for each compound for analysis and construction of a standard curve.
2.4. Cell treatments
Conﬂuent THP-1 cells were harvested by centrifugation at
room temperature (RT) (1000 g for 5 min) and re-suspended at
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well tissue culture plates. Salts were prepared in the same medium at
stock concentrations and added to cell cultures to achieve the required
osmolalities (280–680 mOsm/kg). Control cells were treated with me-
dium alone. In initial experiments, dose responses were conducted. In
subsequent experiments, cells were treated with Arg·Glu, NaCl,
Arg·HCl or NaGlu to achieve the osmolality range (280–680 mOsm/
kg) or the equivalent concentration range 50–200 mM. In some exper-
iments, positive control cells were treated with 0.1 μg/mL lipopolysac-
charide (LPS) from Escherichia coli 055:B5 (Sigma). Cells were
incubated for 4 h or for 24 h at 37 °C in an atmosphere of 5% CO2. Follow-
ing the incubation, the cells were spun at 1000 g at RT for 5 min and re-
suspended in 100 μL phosphate buffered saline (PBS; Sigma) without
calcium and magnesium salts, for determination of cell viability. For
phenotypicmarker expression the cellswere re-suspended in 2%bovine
serumalbumin (BSA; Sigma) in PBS. Supernatants and lysateswere also
harvested for nitric oxide determination. Lysates were obtained by
lyzing the cell pellets in 100 μl of 0.01% Triton X 100 (Sigma).
Conﬂuent ﬁbroblast cells were washed once with PBS and
trypsinized with 0.05% trypsin–ethylenediaminetetraacetic acid
(EDTA; Sigma) for 3–4 min at 37 °C until the cells detached from the
plate. Cells were re-suspended in complete DMEM medium and were
centrifuged at 1000 g RT for 5 min. Cells were re-suspended at 2 × 105
cells/mL in complete DMEM medium in ﬂat-bottomed 24 well tissue
culture plates for 6 h at 37 °C/5% CO2. The cells were then washed
with PBS and treated with the salts formulated as described above but
in DMEM medium without FCS to achieve the required osmolalities
for 24 h. Following the incubation, the cells were trypsinized with
0.05% trypsin–EDTA and re-suspended in 5% FCS/PBS to determine cell
viability.
2.5. Measurement of viability
Cell viability of both ﬁbroblasts and THP-1 cells was routinely deter-
mined by staining of cells with 5 μg/mL propidium iodide (PI) immedi-
ately prior to analysis. Cells (104) were analyzed using a FACSCalibur
ﬂow cytometer (BectonDickinson,Mountain View, CA) and FlowJo soft-
ware (Tree Star Inc., Ashland, OR, USA). Dose response curves were
obtained and IC50 values (the concentration/osmolality required to
cause a 50% loss in viability) calculated using the inbuilt dose–response
ﬁtting function with a nonlinear ﬁt analysis in the OriginPro software
version 9.0.
2.6. Measurement of phenotypic marker expression by ﬂow cytometry
Following treatment of THP-1 cells, phenotypic marker expression
was assessed. Cells were re-suspended in 2% BSA in PBS. Approximately
2 × 105 cells were transferred to individual wells in round bottomed 96
well tissue culture plates and incubated at 4 °C for 15 min. The cells
were washed at 1000 g for 5 min and incubated with the following
monoclonal antibodies at 4 °C for 30min: anti-human leukocyte antigen
antibody (HLA-DR; DAKO, Glostrup, Denmark), anti-human CD54 anti-
body and allophycocyanin (APC)-conjugated anti-human CD86 anti-
body (BD PharMingen, Oxford, UK) at a 1 in 50 dilution. Isotype
controls used were mouse IgG2aκ for anti-human HLA-DR and IgG1κ
(BD PharMingen) for anti-human CD54 antibody and anti-human
CD86 antibody. After incubation, cells were washed twice with PBS
(1000 g for 5 min) followed by a further 30 min incubation at 4 °C
with ﬂuorescein isothiocyanate (FITC)-conjugated F(abʹ)2 goat anti-
mouse IgG at a 1 in 50 dilution (DAKO) for anti-human CD54 and
anti-human HLA-DR antibody stained samples; cells stained with APC-
conjugated anti-human CD86 antibody were incubated with 2% BSA
in PBS. Cells were washed as previously described and ﬁnally re-
suspended in 5% FCS/PBS, and analyzed by FACSCalibur. Dead cells
were excluded from all analyses by stainingwith 5 μg/mL PI immediate-
ly prior to analysis for cells stained for CD54 and HLA-DR; for CD86staining dead cells were excluded following 5 min incubation with
2 μg/mL of 7-aminoactinomycin D (7-AAD; BD PharMingen). For each
sample, a total of 104 viable cells was analyzed.
Flow cytometry data were analyzed using FlowJo v10. Cell debris
was eliminated by gating on the forward scatter (FSC-H) and side scat-
ter (SSC-H) parameters and gates for marker expression were deﬁned
on the basis of isotype control staining. Themean ﬂuorescence intensity
(MFI) and the percentage positive cells were both used as separate indi-
cators of the extent of surface marker expression.
2.7. Flow cytometric analyses for apoptosis and cytotoxicity
The levels of apoptosis/necrosis induced were investigated by stain-
ing of THP-1 cells for annexin V (TACS™ Annexin V-FITC Apoptosis De-
tection kits, R&D Systems Europe, Abingdon, UK). Following 4 h or 24 h
incubation at 37 °C, the cells were incubatedwith PI and annexin V-FITC
as described in themanufacturer's protocol and 104 cells were analyzed
by FACSCalibur and FlowJo. The combination of annexin V-FITC and PI
staining allows for the differentiation between early apoptotic cells
(annexin V+/PI−), late apoptotic cells (annexin V+/PI+), necrotic cells
(annexin V−/PI+) and viable cells (annexin V−/PI−) (Dearman et al.,
2008; Kabakov et al., 2011).
2.8. Analysis of nitric oxide release by Griess assay
The nitrite concentration from supernatants and lysates harvested at
24 h after initiation of THP-1 cell culture was measured by the Griess
assay (Tsikas, 2007) according to the manufacturer's instructions
(Promega, Southampton). A 6-fold dilution series using the nitrite stan-
dard (1.56 to 100 μM) was prepared and added to Maxisorb plastic mi-
crotiter plates (Nunc, Copenhagen, Denmark). Supernatants and lysate
samples were added to the plate and 1% sulfanilamide in 5% phosphoric
acid was added to every well. This was incubated for 10min in the dark.
N-1-napthylethylenediamine dihydrochloride (0.1%) in milliQ water
was then added to every well and incubated for a further 10 min
in the dark. Optical density at 550 nmwasmeasured using an automat-
ed reader (Multiskan, Flow Laboratories, Irvine, Ayrshire, UK). The
nitrite concentrations were determined by plotting the nitrite standard
reference curve and using the associated computer software for
microplate-based assays (Genesis, Life Sciences International Ltd.,
Basingstoke, UK).
2.9. Analysis of IL-8 secretion by enzyme-linked immunosorbant assay
(ELISA)
The IL-8 content of culture supernatants harvested 24 h after initia-
tion of culture of THP-1 cells was measured by sandwich ELISA (Duoset
mouse IL-8 kit; R & D Systems, Abingdon, UK). Maxisorb plastic micro-
titer plates (Nunc, Copenhagen, Denmark) were used for these assays.
Brieﬂy, 96-well plates were coated with 0.1 μg/ml mouse anti-human
IL-8 antibody and incubated overnight at 4 °C. 1% BSA in PBS was
added to all wells to prevent nonspeciﬁc binding and the plates were
placed on anorbital shaker (300 rpm) for 1 h at room temperature. Dou-
bling dilutions of recombinant human IL-8 standard (0.008 to 2 ng/mL)
were added to triplicate wells and supernatant samples diluted to vari-
ous extentswere added in duplicate and plateswere incubated for a fur-
ther 2 h with shaking. Goat anti-human IL-8 antibody (diluted 1 in
5000) was added to each well and the plates were incubated for 2 h.
Streptavidin–horseradish peroxidase (diluted 1 in 1000) was added to
each well and the plates incubated for 30 min in the dark. Between
each step, the plates were washed three times with 0.05% PBS/Tween-
20. Optical density at 450 nm was measured using an automated
reader (Multiskan). A standard curve derivedwithmurine recombinant
cytokine and associated computer software for microplate-based
assays (Genesis) were used to calculate the cytokine concentration in
supernatants.
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The statistical signiﬁcance of differences in chemical or LPS induced
changes inmembranemarker expression, cytokine secretion and cell vi-
ability between experimental and control groups were calculated using
one-way analysis of variance (ANOVA) with a P-value of b0.05 being
considered signiﬁcant.
3. Results
3.1. Effect of Arg·Glu on THP-1 and primary ﬁbroblast cell viability
In initial experiments, the ion-speciﬁc impact of changes in osmolal-
ity on viability of the THP-1 human monocyte cell line (grown as a cell
suspension) was investigated. The excipients Arg·Glu, NaCl, Arg·HCl
and NaGlu were used over a range of concentrations in order to achieve
solution osmolalities in the range of 280–525 mOsm/kg (Fig. 1E). In
these experiments the saltswere added to the standard isotonic cell cul-
ture media, bringing the cumulative osmolality of solution into the hy-
pertonic range. Cell viability was determined using ﬂow cytometry (PI
exclusion) and is illustrated as percentage viable cells for each treat-
ment with respect to both solution osmolality (Fig. 1A) and solution
concentration (Fig. 1B). Baseline viability (in the presence of media
alone) for THP-1 cells was ~90%. Increasing the cumulative osmolality
of the culture media with Arg·Glu, NaCl and NaGlu caused a decrease
in cell viability, with toxicity proﬁles thatwere virtually superimposable
with ~50% toxicity recorded at 450mOsm/kg. However, treatmentwith
Arg·HCl caused a more marked loss in cell viability at much lower cu-
mulative osmolalities, with ~45% toxicity observed at 380 mOsm/kg.
To facilitate direct comparison of the relative amount of each ion re-
quired to cause signiﬁcant toxicity, the same cytotoxicity data are
displayed also as a function of the concentrations of the individual
salts added to the isotonic media (Fig. 1B). This comparison shows
that on amole permole basis, the toxicity proﬁles of NaGlu and Arg·Glu
are superimposable, whereas Arg·HCl and NaCl cause losses in cell via-
bility at lower concentrations (~50% toxicity at 100 mM). In contrast,
the impact on cell viability of addition of Arg·Glu at concentrations
below 100 mM is minimal.
A somewhat different picture was seen when parallel experiments
were conducted with adherent primary human ﬁbroblasts. Fibroblast
cells were cultured at 2 × 105 cells/mL with a range of osmolalities
(280–620 mOsm/kg) of the various salts for 24 h and the cell viability
was determined by PI staining usingﬂow cytometry; data are illustrated
with respect to osmolality (Fig. 1C) and concentration (Fig. 1D). For all
salts therewas a dose dependent decrease in cell viability (reaching sta-
tistical signiﬁcance between 385 and 425 mOsm/kg) and for some salts
(Arg·Glu and NaCl) there was a residual population of ~20% that
remained viable. With respect to osmolality changes, the cytotoxicity
proﬁles of Arg·Glu and Arg·HCl showed a rapid decrease in viability
from 400 mOsm/kg and above, which was very similar to the dose re-
sponse observed for THP-1 cells. Fibroblasts were more resistant to
the effects of NaCl and NaGlu, where a slower decline in viability was
observed until ~525 mOsm/kg, which was followed by a very rapid
drop in viability (Fig. 1C). However, on a molar concentration basis, all
salts with the exception of NaGlu displayed equivalent toxicity over
the range of concentrations examined (50–200 mM) (Fig. 1D). These
data indicate that for the adherent ﬁbroblast cell line, Arg·Glu and
Arg·HCl have some effects on cell viability due to factors in addition to
osmolality.
An alternative way of representing these data for comparative pur-
poses is to calculate the concentration/osmolality that results in a 50%
loss of viability, an IC50 value (Table 1) for each salt. For THP-1 cells,
the IC50 values conﬁrmed that with respect to osmolality, Arg·Glu,
NaCl, and NaGlu had similar effects on viability (values ranging
from 449.1 and 474.3 mOsm/kg) whereas the IC50 value for Arg·HCl
was considerably lower (360.6 mOsm/kg). With respect to molarconcentration, however, IC50 values for NaCl and Arg·HCl were consid-
erably lower (b100 mM) than those recorded for NaGlu and Arg·Glu.
For ﬁbroblast cells, IC50 values for osmolality conﬁrmed that these
cells were more susceptible to Arg·Glu and Arg·HCl than to NaCl and
NaGlu. On a mole for mole basis, similar IC50 values (ranging from
119.1 to 128.0mM)were recorded for all of the salts with the exception
of NaGlu (171.1 mM).
Interestingly, as the independent osmolality measurements show
(Fig. 1E), in practice the increase in osmolality versus concentration of
salt added (Arg·Glu, NaCl, Arg·HCl and NaGlu) is highly dependent on
the nature of the salt, likely due to differences in their degree of dissoci-
ation at equal concentrations. The NaCl salt results in the highest in-
crease in osmolality of the solution, and the Arg·HCl salt the least, for
each given concentration of salt. Thus, considerably higher concentra-
tions of Arg·Glu, Arg·HCl and NaGlu are required to achieve osmolali-
ties equivalent to NaCl (Fig. 1E).
In summary, the key ﬁndings here were that the effects on cell via-
bility were largely consistent with changes in osmolality. However, for
Arg·Glu and Arg·HCl with the adherent cells and for Arg·HCl with the
THP-1 cells, the effects were not solely attributable to osmolality chang-
es. In subsequent experiments, the focus was on THP-1 cells due to the
ability of these cells to act as indicator cells and to respond to danger
signals (Gallo and Gallucci, 2013; Megherbi et al., 2009).
3.2. Toxicity of L-Arg salts for THP-1 cells is not due to nitric oxide
production
A potential mechanism for the additional impact of hypertonic
Arg·HCl on THP-1 cell viability, over and above the effects of changes
in osmolality, was explored. It was hypothesized that the more pro-
found cytotoxic effect of Arg·HCl could be due to the release of nitric
oxide by the cells in the presence of Arg·HCl, as arginine is a substrate
for the formation of nitric oxide (Chen et al., 2013; Chou et al., 2010;
Pekarova et al., 2013). Therefore, the effects of the addition of Arg·Glu,
NaCl, Arg·HCl and NaGlu on nitric oxide production by THP-1 cells
were examined (Fig. 2). Cells were cultured for 24 h in the presence of
50 or 100 mM concentrations of the salts, the latter condition under
which Arg·HCl caused marked toxicity, and supernatants and cell
lysates analyzed for secreted and intracellular levels of nitric oxide, re-
spectively, byGreiss assay. Although thenitric oxide content of superna-
tants derived from cells following treatment with the various salts was
variable (~60% to 140% of control values of 1 μM), such differences were
not statistically signiﬁcant. In contrast, statistically signiﬁcant decreases
in the nitric oxide content of lysates (intracellular nitric oxide content)
were recorded for all treatments (ranging from ~30% to 40% of control
values of 1.2 μM). However, the divergent cytotoxicity proﬁle recorded
for Arg·HCl compared to the other salts could not be reconciled on the
basis of nitric oxide production.
3.3.Mechanism of cell death caused by hypertonic addition of salts to THP-1
cells
In initial experiments (cf Fig. 1) cell viability was assessed using PI
staining which distinguishes dead (necrotic) cells from live cells. In
those experiments, Arg·Glu and NaGlu showed very similar toxicity
proﬁles with respect to solution osmolality and cell death to that
which was observed for the reference excipient, NaCl. However, to fur-
ther characterize the extent and pattern of cell death occurring, and to
conﬁrm that the mechanism of cell death was indeed similar between
Arg·Glu and NaCl, a combination of PI and annexin V-FITC staining
was used. This combination allows for the distinction between early
apoptotic cells (annexin V-FITC positive), late apoptotic cells (annexin
V-FITC and PI positive), necrotic cells (PI positive) and viable cells
(unstained) (Kabakov et al., 2011). THP-1 cells were treated with
50–200 mM concentrations of the salts, or with medium alone, for 4 h
or 24 h, stained with annexin V-FITC and PI and analyzed using a
Table 1
IC50 values calculated additive concentrations and osmolalities required to achieve 50%
drop in viability for THP-1 cells or ﬁbroblasts for each of the salts; raw data displayed in
Fig. 1.
Additives THP-1 cells Fibroblast
[Salt], mM mOsm/kg [Salt], mM mOsm/kg
Arg·Glu 141.1 449.1 119.1 417.4
NaCl 99.6 456.4 114.7 482.9
Arg·HCl 94.3 360.6 128.0 400.7
NaGlu 158.6 474.3 171.1 489.7
Fig. 1.Effect of changes in osmolality on THP-1 cell orﬁbroblast viability: comparisons of different salts THP-1 cellswere seeded into 24-well plates at 106 cells/mL in serum freeRPMImedia (A,
B) or human primary ﬁbroblastswere seeded at 2 × 105 cells/mL in complete DMEMmedium inﬂat-bottomed 24well plates for 6 h at 37 °C (C, D). Cellswere cultured in serum freemedia for
24 h at 37 °C with varying concentrations of NaCl (○), Arg·Glu (●), Arg·HCl (■) and NaGlu (Δ) spanning a range of osmolalities from 280 to 525mOsm/kg (A) or from 280 to 625mOsm/kg
(C) and a range of concentrations from 0 to 250 mM (B) or from 0 to 325 mM (D). Control cells were cultured with medium alone (280 mOsm/kg). Following culture, ﬁbroblasts were
trypsinized and THP-1 and ﬁbrobalsts were harvested and cell viability was determined using PI. Cells (10,000) were analyzed by ﬂow cytometry using a FACSCalibur ﬂow cytometer for PI
staining (FL2 channel; viability) against forward scatter (FSC; size). Data are displayed as % cell viability for n = 3–6 experiments (mean and SE) versus excipient with respect to
cumulative osmolality (A, C) and the concentrations of each excipient required to achieve the required osmolality (B, D). The statistical signiﬁcance of differences between cells cultured in
medium alone (isotonicity) and cells treated with various concentrations of salts was assessed by one way ANOVA (p b 0.05; * = NaCl, # = Arg·Glu, ¥ = Arg·HCl, δ=NaGlu). For clarity
of presentation, only the ﬁrst concentration of each salt preparation at which there was a signiﬁcant loss of cell viability is illustrated. The relationship between each individual salt
concentration as formulated in RPMI media and cumulative osmolality as measured using an osmometer is illustrated in (E).
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sen on the basis of preliminary kinetics experiments that revealed that
after 2 h incubation there was little impact on THP-1 cell viability or ap-
optosis, whereas after 4 h, signiﬁcant effects were observed at concen-
trations of N150 mM (data not shown). The 24 h time point was
utilized to determine whether lower concentrations (b100 mM) of
salts that were without effect on cell viability as measured by PI exclu-
sion at this time point (cf Fig. 1) had more subtle effects on apoptosis.
Representative quadrant plots are displayed in Fig. 3, illustrating the
gating strategy and showing examples of predominantly viable cells
(Fig. 3A, 94.5% cells in lower left quadrant), populations of early and
late apoptotic cells (Fig. 3B; 33% and 42%, respectively, in the lower
Fig. 2. Impact of Arg·Glu and other salts on THP-1 cell nitric oxide production THP-1 cells were seeded into 24-well plates at 106 cells/mL in serum free RPMImedia andwere cultured for
24 h at 37 °C in medium alone (represented by the dashed line) or in the presence of 50 mM (open column) or 100 mM (closed column) Arg·Glu, NaCl, Arg·HCl or NaGlu. Supernatants
(A) and lysates (B) were collected after the 24 h incubation and the nitrite concentrationwas determined by the Griess assay. The nitric oxide content of themedia (with supplements) in
the absence of cells was also determined (dotted line). The nitrite concentrations were determined using a nitrite standard reference curve and the associated computer software for
microplate-based assays and data are displayed as nitrite concentration (μM; mean and SE). The statistical signiﬁcance of differences in the nitrite content of samples from cells
cultured in medium alone and cells treated with various concentrations of salts was assessed by one way ANOVA (*p b 0.05).
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85.5% of cells in upper right quadrant) and populations containing ne-
crotic cells (Fig. 3D; 15.5% cells in the upper left quadrant).Fig. 3. The gating strategy for the characterization of the mechanism of cell death (represent
cultured for 24 h in serum free RPMI media alone (A), or in the presence of 150 mM NaGlu (B
annexin V-FITC (FL-1 channel) and PI (FL-2 channel) and 10,000 cells were analyzed using
showing the pattern of cytotoxicity for each treatment group; in each case the lower left qua
annexin V + ve/PI-ve (early apoptotic) cells, the upper right quadrant represents annexin V +
PI + ve (necrotic) cells. The percentage of cells in each quadrant is indicated.Culture of THP-1 cellswith 50 or 100mMof the salts for 4 h had little
impact on cell viability (Fig. 4A-D), although there was a signiﬁcant loss
in viability for all 4 salts at concentrations of 150 mM and above. Thisative FACS histograms) THP-1 cells were seeded into 24-well plates at 106 cells/mL and
), 200 mM Arg·Glu (C), 200 mM NaCl (D). Following incubation, cells were stained with
a FACSCalibur ﬂow cytometer. Data are displayed as representative quadrant analyses
drant represents Annexin V-ve/PI-ve (viable) cells, the lower right quadrant represents
ve/PI + ve (late apoptotic) cells and the upper left quadrant represents annexin V-ve/
Fig. 4. Characterization of the mechanism of cell death THP-1 cells were seeded into 24-
well plates at 106 cells/mL in serum free RPMI media and were cultured for 4 h (A–D) or
24 h (E–H) at 37 °C in the presence of 50–200 mM NaCl (○), Arg·Glu (●), Arg·HCl (■)
or NaGlu (Δ). Control cells were cultured with medium alone. To characterize the extent
and pattern of induced cytotoxicity, cells were stained with Annexin V-FITC (FL-1
channel) and PI (FL-2 channel) and 10,000 cells were analyzed using a FACSCalibur ﬂow
cytometer. The results are displayed as the percentages of cells that are Annexin V-ve/
PI-ve (viable) (A, E), Annexin V + ve/PI-ve (early apoptotic) (B, F), Annexin V + ve/
PI + ve (late apoptotic) (C, G), Annexin V-ve/PI + ve (necrotic) (D, H). In each case,
data are shown as % total cells in each category (mean and SE for n = 3 experiments,
where for clarity SE N 2% only are shown). The statistical signiﬁcance of differences
between cells cultured in medium alone and cells treated with various concentrations of
salts was assessed by one way ANOVA (p b 0.05; * = NaCl, # = Arg·Glu, ¥ = Arg·HCl,
δ=NaGlu).
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crotic cells, with the exception of NaGlu, which caused a more marked
loss in viability than did the other salts, and this was paralleled by an in-
creased frequency of early apoptotic cells (Fig. 4B). After 24 h in culture,
only the 50 mM concentration of each of the salts was without signiﬁ-
cant effects on cell viability. In each case at doses of 100 mM and
above there was a signiﬁcant drop in the frequency of viable cellswhichwas reﬂected by a corresponding signiﬁcant increase in late apo-
ptotic cells, with no marked changes in early apoptotic or necrotic cells
(Fig. 4E–H). Consistent with the previous data (cf Fig. 1B) where viabil-
ity was assessed simply as a function of PI exclusion, for a given concen-
tration of salt, NaCl and Arg·HCl were considerablymore cytotoxic than
NaGlu or Arg·Glu and this resulted in increased numbers of late apopto-
tic cells.
These data demonstrate that the mechanism of cell death is very
similar betweenNaCl and Arg·Glu, with loss of viability being paralleled
in both cases by increased frequency of late apoptotic cells with little
evidence of early apoptotic or necrotic cells.
3.4. Impact of hypertonic concentrations of salts on markers of THP-1 cell
activation
It is clear from the experiments described thus far that high concen-
trations (N150 mM) of Arg·Glu and other ions impact markedly on cell
viability over a 24 h culture period. In subsequent experiments, more
subtle effects on the activation status of the cells were explored under
conditions where the impact on cell viability was marginal. Changes in
membrane marker (CD54, HLA-DR and CD86) expression were mea-
sured on resting THP-1 cells and cells stimulated with the toll-like re-
ceptor (TLR) 4 ligand LPS, a polyclonal activator of monocytes (Rossol
et al., 2011). Resting THP-1 cells were ~20% CD54 + ve, 60% HLA-
DR+ve and b5% CD86+ve. Treatmentwith LPS increased signiﬁcantly
the frequency of CD54 + ve cells (to ~90%) and also upregulated the
level of expression (increasing MFI from ~60 au to 360 au) but was
without marked effect on levels of the other markers. The presence of
the various salts was also without impact on resting levels of HLA-DR
and CD86 (data not shown). With respect to CD54 expression, 50 mM
of the salts were largely without effect on either the frequency of posi-
tive cells or the extent of expression, whereas 100 mM of each of the
salts tended to cause a small increase (to ~40%) in the proportion of
CD54+ cells and a slight increase in MFI to ~120 au for NaCl. However,
none of these small changes reached statistical signiﬁcance (Fig. 5A and
B). Finally, the impact of Arg·Glu and NaCl on production of the proin-
ﬂammatory cytokine IL-8 was examined. Cells cultured with medium
alone did not secrete detectable levels of IL-8 (b0.1 ng/mL)whereas cul-
ture in the presence of LPS induced detectable cytokine expression
(~1 ng/mL) (Fig. 5C). There was some inter-experimental variation,
but treatment with a range of concentrations of Arg·Glu or NaCl did
not result in signiﬁcant cytokine production.
4. Discussion
The impact of the excipientArg·Glu and other related salts on cell vi-
ability and cellular stress using in vitro cell culture systems has been ex-
amined. These studies have demonstrated that Arg·Glu does not have
any further detrimental effects on viability of the monocyte (DC surro-
gate) THP-1 cell line in comparison to NaCl at equivalent osmolalities,
and that relatively high concentrations of both salts cause cell death
by apoptosis. In contrast, Arg·HCl was more toxic to this cell line at
equivalent osmolalities. For human primary ﬁbroblasts that grow as
an adherent monolayer, all salts caused signiﬁcant toxicity at 385 and
425 mOsm/kg, although Arg·Glu and Arg·HCl caused a more precipi-
tous subsequent decline in viability than did NaCl or NaGlu. These
data suggest that salts containing arginine have an impact on cell viabil-
ity of adherent cells that is in addition to effects due to hypertonicity and
that in the case of Arg·Glu can only be partially ameliorated by the pres-
ence of Glu. Therewas some indication that the arginine containing salts
affected cell adherence/morphology of the primary human ﬁbroblasts
(data not shown). Indeed there is some precedent for hypertonicity
impacting on the cytoskeleton, with adherent human monocytes and
macrophages showing changes in microtubule organisation upon hy-
pertonic stress (400mOsm/kgNaCl) (Nunes et al., 2013). It is of interest
that the polystyrene tissue culture plates in which the primary human
Fig. 5. Effects of Arg·Glu and other salts on CD54 expression and IL-8 production THP-1 cells were seeded into 24-well plates at 106 cells/mL in serum free RPMImedia and were cultured
for 24 h at 37 °Cwithmediumalone or in the presence of 50–200mMof Arg·Glu,NaCl, Arg·HCl orNaGlu. Positive control cellswere culturedwith LPS (0.1 μg/mL). At the endof the culture
period, cells were stained for expression of CD54 or with isotype control (mouse IgG1κ) antibody and dead cells were excluded with PI. Data (10,000 cells) were acquired using a
FACSCalibur ﬂow cytometer and results are displayed as percentage positive cells (A) and mean ﬂuorescence intensity (arbitrary units; au) (B) (mean and SE for six independent
experiments). Following culture, samples were centrifuged at 1000 rpm for 5 min and supernatants were collected and analyzed for IL-8 content by ELISA (C). Results are displayed as
mean and SEM of 3 independent experiments. The statistical signiﬁcance of differences between cells cultured in medium alone and cells treated with various concentrations of salts
or LPS was assessed by one way ANOVA (*p b 0.05).
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polystyrene and ensure a negative charge, conditions which promote
cell adherence (Curtis et al., 1983). It may be that the positively charged
arginine ion in the Arg·Glu and Arg·HCl preparations interferewith this
interaction through salt screening of the net surface charge.
It is of interest that in the nonadherent indicator cell line (THP-1),
Arg·HCl was more toxic than the other salts, for a given osmolality.
For the nonadherent cell line, the presence of Glu in the Arg·Glu prepa-
ration reduced this toxicity. One possible explanation for this increased
toxicity was that arginine was acting as a substrate for the formation of
nitric oxide (Chen et al., 2013; Chou et al., 2010; Pekarova et al., 2013),
which interacts with superoxide radicals to form peroxynitrite, causing
oxidative damage to cells (Calcerrada et al., 2011). Clearly the THP-1
cells were able to secrete detectable nitric oxide (~1 μMwas measured
in the supernatants, levels some 50-fold higher than that recorded in
the absence of cells), amounts similar to those recorded previously for
the same cell line under the same culture conditions (~2.5 M) (Garg
et al., 2005). Interestingly, there was no differential effect of arginine
on nitric oxide production. However, all salts caused a signiﬁcant de-
crease in intracellular nitric oxide, even under conditions (50 mM)
where there was no effect on viability, suggesting that this may be
due to hypertonicity. Indeed, it has been reported previously in other
cell types (muscle cells and in cartilage) that exposure to hypertonic
concentrations of NaCl and sucrose ormannitol results in reduced levels
of nitric oxide and the enzyme inducible nitric oxide synthase (Le et al.,
2006; Pingle et al., 2003). Thus, hypertonicity per se may trigger de-
creases in expression of nitric oxide. It should be noted that the assay
utilized herein is an approximation of nitric oxide content, as it mea-
sures nitrite (NO2−) only, which is one of two primary, stable and non-
volatile breakdown products of nitric oxide, the other being nitrate(NO3−)(Tsikas, 2007). The mechanism by which Arg·HCl is more
toxic for the nonadherent cell line than the other salts is unclear at
present, however, the presence of Glu in the Arg·Glu mixture appears
to ameliorate this toxicity.
The experiments conducted herein have demonstrated that hyper-
tonic stress induced by all 4 salts tested resulted in cell death by apopto-
sis (with the majority of cells in the late apoptotic stage by 24 h) with
very little necrosis occurring at any concentration. This is a key ﬁnding
given the fact that cells that die by necrosis expel their contents when
they lyse, including inﬂammatory cytokines that stimulate further
pro-inﬂammatory responses (Rock and Kono, 2008). In contrast, cells
that die by apoptosis are compacted into apoptotic bodies as a mecha-
nism to avoid immune activation and instead are phagocytosed
(Biermann et al., 2013). One of the earliest signs of apoptosis is the
translocation of the membrane phospholipid phosphatidylserine from
the inner to the outer leaﬂet of the plasma membrane. This molecule
is recognized by phagocytes, triggering phagocytosis and also the pro-
duction of anti-inﬂammatory cytokines, resulting in efﬁcient removal
of the dying cell without inﬂammation. In the ﬂow cytometric analyses
of apoptosis, it is the expression of this cell surface phosphatidylserine
that is detected by the binding of the ﬂuorescently labelled ligand
annexin V (Kabakov et al., 2011). Although there have been suggestions
that late apoptotic cells more closely resemble necrotic cells, due to
their compromised cell membranes, in fact it has been shown that
both early and late apoptotic cells induce the differential signalling
pathways in macrophages compared with necrotic cells and that intra-
cellular contents released from late apoptotic cells are neutral and not
proinﬂammatory (Patel et al., 2006). The fact that all of the salts exam-
ined caused death by apoptosis is not simply a feature of the target THP-
1 cell, as it has been demonstrated previously that under the right
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dergo necrosis (Melehani et al., 2015). It is of interest that all of the salts
caused cell death by the samemechanismandwith similar kinetics. This
suggests that induction of apoptosis is a common feature of hypertonic
insult which is consistent with previous studies in which hyperosmotic
stress has been shown to induce apoptosis, particularly in kidney
cells (Alﬁeri and Petronini, 2007). There are fewer studies in which
monocyte or DC populations have been investigated, but here too the
mechanism of monocyte cell death induced by osmolytes such as NaCl
and mannitol at 500 mOsm/kg has been shown to be apoptosis
(Gastaldello et al., 2008). To our knowledge there have been no previ-
ous studies on the mechanism of Arg·Glu induced cytotoxicity. Thus,
all the salts including Arg·Glu induce the THP-1 cells to undergo apo-
ptosis, in which case this is not expected to result in inﬂammation.
More subtle effects of the salts on the THP-1 indicator cell line
were explored: the impact on markers of cellular stress/cell maturation
such as changes in expression of the membrane marker CD54
(intercellular adhesion molecule-1; ICAM-1) and production of the
pro-inﬂammatory cytokine IL-8. ICAM-1 is an adhesion molecule that
is a member of the immunoglobulin superfamily with functions that
relate to its role in cell adhesion and migration (Simmons, 1995). Its li-
gands include the matrix factor hyaluronan and lymphocyte function-
associated antigen-1 on T cells; interactionwith its T cell ligand provides
costimulation and therefore activation of the adaptive immune re-
sponse (Simon et al., 1991). IL-8 is an inducible chemokine whose pro-
duction is stimulated in various cell types by other proinﬂammatory
cytokines such as IL-1 and TNF-α. IL-8 plays a key role in acute inﬂam-
mation, being the main chemotactic factor for neutrophils, the most
important phagocytic cell inmany different types of inﬂammatory reac-
tion and may also play a role in macrophage and ﬁbroblast chemotaxis
(Harada et al., 1994). These two markers have been shown to be indic-
ative of the activation of DC-like cells such as the THP-1 cell line. Thus,
TLR ligands including TLR1, TLR2 and TLR4 each caused increased
ICAM-1 expression and IL-8 secretion by THP-1 cells (Lee et al., 2011;
Spachidou et al., 2007). Furthermore, less vigorous stimuli, such as
chemicals that have the ability to cause contact allergy, a T cellmediated
delayed type hypersensitivity in the skin, upregulate the same markers
on THP-1 cells in culture (Megherbi et al., 2009; Tuschl and Kovac,
2001). In the experiments described herein, consistent with the pub-
lished data, stimulation of THP-1 cells with the TLR4 ligand LPS resulted
in the expected up-regulation of these markers, with increases in both
the number of ICAM-1 positive cells and the amount expressed per
cell. In contrast, treatment with the salts was without marked effects
on expression of the membrane marker or cytokine expression; for
both Arg·Glu and NaCl therewere similar, but variable, low level effects
on bothmarkers that did not reach statistical signiﬁcance. There is some
evidencewith other cell lines that hyperosmolalitymay impact on cyto-
kine expression, particularly for endothelial and epithelial cell lines.
Thus, hypertonic concentrations of NaCl andmannitol increased IL-8 ex-
pression by Caco-2 and HT-29 cells (human intestinal epithelial cell
lines) and by bronchial epithelial cells (NCl-H292) (Hashimoto et al.,
1999; Hubert et al., 2004; Németh et al., 2002). In both cell types, induc-
tion of IL-8 was via a p38mitogen-activated protein kinase. Interesting-
ly, for the human intestinal epithelial cell lines, hypo-osmolality
(163 mOsm/L NaCl) was considerably more stimulatory than was
hyperosmolality (496mOsm/L NaCl)with respect to cytokine induction
(Hubert et al., 2004). It could be argued that for tissues such as the gas-
trointestinal tract, exposure to marked ﬂuctuations in osmolarity is a
feature of normal physiology and as such these cells are required to
sense and respond to such changes (Brocker et al., 2012). In contrast,
there are far fewer reports regarding the response of monocytes/
macrophages or DC to hyperosmotic stress (induced by either NaCl or
glycerol/mannitol), and conﬂicting results have been generated. It has
been reported that hypertonicity had no impact on basal IL-8 release
and inhibited LPS-induced expression of this cytokine by freshly isolat-
ed human bloodmonocytes (Brulez et al., 1999), whereas others reportthat human peripheral blood mononuclear cells respond to NaCl by up-
regulating IL-8 and IL-1β, the latter at the level ofmessage only (Shapiro
andDinarello, 1997). Furthermore, it has been demonstrated that hypo-
tonicity, but not hypertonicity, activates macrophage and monocyte
caspase 1 (IL-1β processing enzyme) and induces IL-1β release as a
result of cell swelling (Compan et al., 2012; Perregaux et al., 1996). Con-
ﬂicting data have been reported, with hyper-osmotic stress upregulat-
ing caspase 1, but here macrophages were primed with LPS (Ip and
Medzhitov, 2015). As such, the experiments reported herein conﬁrm
that in the absence of priming, hypertonicity caused by Arg·Glu or
NaCl fails to impact signiﬁcantly on monocyte IL-8 production, over a
range of doses that spanned concentrations that impacted on cell viabil-
ity. In regard to excipient concentrations, it should be remembered that
immediately following subcutaneous injection the vehicle in which the
drug is formulated disperses. This exchange into a physiological medi-
um, with concomitant decrease in excipient concentration, may have
biophysical consequences and the in vivo local cellular response is yet
to be determined (Kinnunen and Mrsny, 2014).
In conclusion, adherent and nonadherent cell lines exhibit very sim-
ilar toxicity proﬁles for Arg·Glu, and for the nonadherent cell line, the
data are consistent with the toxicity being due to changes in osmolality.
In common with hypertonic concentrations of NaCl, the mechanism of
cell death is via apoptosis and is thus not pro-inﬂammatory, which is
conﬁrmed by the negative ﬁndings for markers of cellular stress or acti-
vation (membrane marker and proinﬂammatory cytokine expression).
Taken together these data indicate that Arg·Glu is of equivalent toxicity
to NaCl and that the use of Arg·Glu as an excipient for subcutaneous in-
jection is not expected to result in atypical inﬂammation.
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